Proteasome inhibitors restore the STAT1 pathway and enhance the expression of MHC class I on human colon cancer cells

Abstract Background A new strategy, particularly a novel combination, for immunotherapy in microsatellite stable metastatic colorectal cancer (mCRC) treatment needs to be formulated. Studies on the interferon-γ (IFN-γ)/ Janus kinase (JAK)/ signal transducer and activator of transcription (STAT)1 pat...

Full description

Bibliographic Details

Published in:	Journal of Biomedical Science
Main Authors:	Yi-Hsin Liang, Kuo-Hsing Chen, Jia-Huei Tsai, Yung-Ming Cheng, Chang-Cheng Lee, Chiu-Hwa Kao, Kuang-Yu Chan, Yeh-Ting Chen, Wen-Ling Hsu, Kun-Huei Yeh
Format:	Article
Language:	English
Published:	BMC 2021-11-01
Subjects:	Colorectal cancer Major histocompatibility complex (MHC) class I Proteasome inhibitors STAT1 Tumor infiltrating lymphocytes (TILs) Interferon-γ (IFN-γ)
Online Access:	https://doi.org/10.1186/s12929-021-00769-9